A detailed history of Raymond James & Associates transactions in Becton Dickinson & CO stock. As of the latest transaction made, Raymond James & Associates holds 578,920 shares of BDX stock, worth $131 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
578,920
Previous 600,248 3.55%
Holding current value
$131 Million
Previous $140 Million 0.5%
% of portfolio
0.09%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$221.47 - $242.41 $4.72 Million - $5.17 Million
-21,328 Reduced 3.55%
578,920 $140 Million
Q2 2024

Jul 19, 2024

SELL
$225.07 - $246.17 $1.13 Million - $1.24 Million
-5,036 Reduced 0.83%
600,248 $140 Million
Q1 2024

Apr 22, 2024

BUY
$233.45 - $247.73 $9.85 Million - $10.5 Million
42,202 Added 7.49%
605,284 $150 Million
Q4 2023

Jan 16, 2024

SELL
$232.24 - $267.23 $30.6 Million - $35.3 Million
-131,934 Reduced 18.98%
563,082 $137 Million
Q3 2023

Oct 24, 2023

SELL
$254.9 - $283.59 $4.55 Million - $5.06 Million
-17,833 Reduced 2.5%
695,016 $180 Million
Q2 2023

Jul 25, 2023

SELL
$238.39 - $265.32 $997,185 - $1.11 Million
-4,183 Reduced 0.58%
712,849 $188 Million
Q1 2023

Apr 14, 2023

BUY
$229.71 - $259.35 $2.71 Million - $3.06 Million
11,818 Added 1.68%
717,032 $177 Million
Q4 2022

Feb 08, 2023

SELL
$218.29 - $256.91 $14.8 Million - $17.4 Million
-67,922 Reduced 8.79%
705,214 $179 Million
Q3 2022

Oct 25, 2022

SELL
$51.03 - $264.23 $561,585 - $2.91 Million
-11,005 Reduced 1.4%
773,136 $172 Million
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $8.54 Million - $10 Million
36,365 Added 4.86%
784,141 $193 Million
Q1 2022

May 11, 2022

BUY
$243.64 - $270.48 $12.6 Million - $14 Million
51,830 Added 7.45%
747,776 $199 Million
Q4 2021

Feb 08, 2022

BUY
$230.08 - $250.94 $16.7 Million - $18.2 Million
72,535 Added 11.64%
695,946 $175 Million
Q3 2021

Nov 02, 2021

BUY
$232.72 - $256.47 $290,201 - $319,818
1,247 Added 0.2%
623,411 $153 Million
Q2 2021

Aug 11, 2021

SELL
$232.65 - $254.58 $40.1 Million - $43.9 Million
-172,306 Reduced 21.69%
622,164 $151 Million
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $6.94 Million - $7.68 Million
29,904 Added 3.91%
794,470 $193 Million
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $3.25 Million - $3.61 Million
14,659 Added 1.95%
764,566 $191 Million
Q3 2020

Nov 04, 2020

BUY
$215.77 - $276.76 $8.58 Million - $11 Million
39,772 Added 5.6%
749,907 $175 Million
Q2 2020

Jul 28, 2020

BUY
$219.9 - $263.41 $4.48 Million - $5.36 Million
20,364 Added 2.95%
710,135 $170 Million
Q1 2020

Apr 21, 2020

BUY
$195.69 - $279.01 $21.9 Million - $31.3 Million
112,053 Added 19.4%
689,771 $159 Million
Q4 2019

Feb 12, 2020

SELL
$236.45 - $266.82 $1.67 Million - $1.89 Million
-7,065 Reduced 1.21%
577,718 $157 Million
Q3 2019

Nov 07, 2019

BUY
$230.58 - $256.08 $5.71 Million - $6.34 Million
24,772 Added 4.42%
584,783 $148 Million
Q2 2019

Aug 06, 2019

BUY
$217.4 - $246.08 $7.9 Million - $8.94 Million
36,342 Added 6.94%
560,011 $141 Million
Q1 2019

May 06, 2019

BUY
$206.05 - $248.17 $3.75 Million - $4.51 Million
18,193 Added 3.6%
523,669 $131 Million
Q4 2018

Feb 11, 2019

SELL
$204.73 - $257.93 $679,498 - $856,069
-3,319 Reduced 0.65%
505,476 $114 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $6.28 Million - $6.9 Million
26,952 Added 5.59%
508,795 $133 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $11.6 Million - $13 Million
55,763 Added 13.09%
481,843 $115 Million
Q1 2018

May 14, 2018

BUY
$205.46 - $240.27 $12.9 Million - $15 Million
62,549 Added 17.21%
426,080 $92.3 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $9.84 Million - $11.6 Million
52,064 Added 16.72%
363,531 $77.8 Million
Q3 2017

Nov 13, 2017

SELL
$186.89 - $198.9 $1.79 Million - $1.9 Million
-9,568 Reduced 2.98%
311,467 $61 Million
Q2 2017

Aug 14, 2017

BUY
N/A
321,035
321,035 $62.6 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.